Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2024
Sex-specific effects of PNPLA3 I148MAlessandro Cherubini, Chiara Rosso, Sara Della Torre
Expert Opinion on Therapeutic Targets|December 14, 2021
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to dateAlessandro Cherubini, Elia Casirati, Melissa Tomasi, et al.
Trends in Molecular Medicine|June 18, 2024
Sexual dimorphism of metabolic dysfunction-associated steatotic liver diseaseAlessandro Cherubini, Sara Della Torre, Serena Pelusi, et al.
Oncotarget|May 10, 2014
The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic targetMaurizio Orlandini, Federico Galvagni, Monia Bardelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2026
Autophagy in MASLD: A Metabolic and Precision Medicine PerspectiveAlessandra Cazzaniga, Silvia Frigo, Alessandro Cherubini, et al.
Biomedical Optics Express|September 14, 2020
High-throughput 3D imaging of single cells with light-sheet fluorescence microscopy on chipFederico Sala, Michele Castriotta, Petra Paiè, et al.
Cells|December 1, 2019
NG2 as an Identity and Quality Marker of Mesenchymal Stem Cell Extracellular VesiclesMario Barilani, Valeria Peli, Alessandro Cherubini, et al.
The FEBS Journal|January 29, 2026
ER proteostasis meets mitochondrial function: contact sites as hubs of communication and therapeutic targetsGiorgia Maria Renna, Alessandro Cherubini, Ersilia Varone, et al.
JHEP Reports : Innovation in Hepatology|September 23, 2024
Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver diseaseClara Meda, Valeria Benedusi, Alessandro Cherubini, et al.
Pageof 8